{'fraction_non_alphanumeric': 0.017721518987341773, 'fraction_numerical': 0.0, 'mean_word_length': 6.126126126126126, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated disease that targets the peripheral nerves and causes progressive weakness and sensory loss. If left untreated, it can become disabling, with loss of ability to ambulate, work, or function independently. There are no established guidelines for the clinical diagnosis and therapy of CIDP, and consequently, many patients remain undiagnosed or are denied treatment. The Neuropathy Association therefore developed the following guidelines for the clinical diagnosis and treatment of CIDP, based on the available medical and scientific literature and the recommendations made by its medical advisory committee.